Systematic review highlights dengue incidence in military personnel, suggesting improvements in diagnostics and prevention measures.
Background Military deployments to dengue-endemic regions present ongoing risks to health and mission readiness. This review synthesizes a century of evidence on the incidence, clinical features, diagnostics, and prevention of dengue in military personnel, aiming to guide future health policies, research, and Force Health Protection strategies. Methods Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, a search of PubMed and Google Scholar (March 15–April 5, 2025) identified 32 English-language studies (1905–2024) reporting primary data on dengue in military personnel. Studies were selected based on predefined criteria and narratively synthesized. Results A review of 32 studies involving 51,213 military personnel across 41 deployment settings identified 73,156 dengue cases, with outbreaks dating back to 1904. A notable spike occurred between 2012 and 2017, likely due to increased deployments to endemic regions and better surveillance. In 2023 alone, 4,903 US cases were confirmed. Diagnostic methods have advanced from early clinical recognition to modern Non-structural Protein 1 (NS1) antigen and Polymerase Chain Reaction (PCR) tests. Common symptoms included high fever, intense headache, and myalgia. Despite efforts such as integrated vector control and Personal Protective Measures (PPMs), and new vaccines (Qdenga®, Takeda), prevention remains limited by inconsistent use of integrated vector control and PPMs, low vaccine uptake, and eligibility constraints. Conclusion Dengue continues to threaten operational readiness in tropical deployments. Strengthening integrated vector control, PPMs, vaccination, and real-time surveillance is crucial to reduce its impact and control other co-endemic diseases like malaria, yellow fever, chikungunya, and Zika. Future research should focus on evaluating integrated vaccine and vector control strategies aimed at enhancing Force Health Protection among military personnel.
No takes yet. Share an insight, caveat, or question.
Agboli et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: